Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Globus Medical Inc
(NY:
GMED
)
53.06
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Mar 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
53.06
Bid (Size)
37.32 (2)
Ask (Size)
54.00 (1)
Prev. Close
53.06
Today's Range
53.06 - 53.06
52wk Range
43.38 - 62.88
Shares Outstanding
135,372,391
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
From Six Figures to Seven: 3 Robotics Stocks Set to Make Millionaires
March 24, 2024
With automated machines set to integrate into everyday functionalities, these are the robotics stocks that could make you rich.
Via
InvestorPlace
Don't overlook NYSE:GMED—a stock with solid growth prospects and a reasonable valuation.
March 21, 2024
For those who appreciate growth without the sticker shock, GLOBUS MEDICAL INC - A (NYSE:GMED) is worth considering.
Via
Chartmill
Performance
YTD
-0.19%
-0.19%
1 Month
-5.10%
-5.10%
3 Month
-0.19%
-0.19%
6 Month
+6.20%
+6.20%
1 Year
-0.26%
-0.26%
More News
Read More
The Latest Analyst Ratings For Globus Medical
March 18, 2024
Via
Benzinga
7 Robotic Surgery Stocks to Buy for the Future of Healthcare
March 13, 2024
Via
InvestorPlace
Exploring GLOBUS MEDICAL INC - A's Technical Signals and Breakout Potential.
March 11, 2024
Via
Chartmill
NYSE:GMED is not too expensive for the growth it is showing.
February 28, 2024
Via
Chartmill
Key Takeaways From Globus Medical Analyst Ratings
February 21, 2024
Via
Benzinga
Globus Medical: Q4 Earnings Insights
February 20, 2024
Via
Benzinga
Why NYSE:GMED Is a Standout High-Growth Stock in a Consolidation Phase.
January 30, 2024
Via
Chartmill
Globus Medical (GMED) Q4 2023 Earnings Call Transcript
February 20, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Globus Medical Reports Fourth Quarter and Full Year 2023 Results
February 20, 2024
From
Globus Medical
Via
GlobeNewswire
Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
February 13, 2024
From
Globus Medical
Via
GlobeNewswire
Investors seeking growth at a reasonable cost should explore NYSE:GMED.
February 07, 2024
Via
Chartmill
The Analyst Verdict: Globus Medical In The Eyes Of 6 Experts
January 11, 2024
Via
Benzinga
NYSE:GMED qualifies as a high growth stock and is consolidating.
January 09, 2024
Via
Chartmill
Investors seeking growth at a reasonable cost should explore NYSE:GMED.
December 25, 2023
Via
Chartmill
Earnings Scheduled For February 20, 2024
February 20, 2024
Via
Benzinga
Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer
February 05, 2024
From
Globus Medical
Via
GlobeNewswire
Do Investors Have Too Much Money Out of the Market?
January 28, 2024
Via
The Motley Fool
NYSE:GMED stands out as a growth opportunity that won't break the bank.
January 17, 2024
Via
Chartmill
7 Healthcare Stocks Taking Medicine to the Next Level
January 14, 2024
Via
InvestorPlace
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
January 10, 2024
From
Globus Medical
Via
GlobeNewswire
Assessing Globus Medical: Insights From 5 Financial Analysts
December 20, 2023
Via
Benzinga
3 Stocks at the Forefront of Medical Robotics
December 10, 2023
Via
InvestorPlace
For those who appreciate growth without the sticker shock, NYSE:GMED is worth considering.
December 04, 2023
Via
Chartmill
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.